Spencer Lau, DO
General Practice · Honolulu, HINPI 1427194083
Payments from drug & device makers
Across 54 payments — averaging $44.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$552
- Eisai Inc.$312
- Medtronic$226
- MML US, Inc.$176
- Lilly USA, LLC$174
- Teva Pharmaceuticals USA, Inc.$152
- plus $823 from 12 others
What the payments were for
- Food & beverage$2,415100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $552 |
| Eisai Inc. | 6 | $312 |
| Medtronic | 2 | $226 |
| MML US, Inc. | 1 | $176 |
| Lilly USA, LLC | 7 | $174 |
| Teva Pharmaceuticals USA, Inc. | 3 | $152 |
| Pfizer | 2 | $135 |
| AstraZeneca | 1 | $125 |
| Vertex | 1 | $122 |
| Bayer | 1 | $111 |
| Boston Scientific | 1 | $106 |
| Amgen(2 entities) | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Novo Nordisk | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| GSK | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Abbott | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,415 in reported general payments places this provider in the 85th percentile of 650 general practice providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 64 | $59,968 |
| JanuviaSitagliptin Phosphate | 12 | $20,014 |
| NucyntaTapentadol Hcl | 12 | $15,394 |
| Oxycodone Hcl | 811 | $13,929 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 405 | $13,160 |
| Morphine Sulfate ErMorphine Sulfate | 269 | $10,181 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 38 | $9,448 |
| Methadone Hcl | 209 | $4,425 |
| Hysingla ErHydrocodone Bitartrate | 14 | $4,073 |
| Morphine Sulfate | 118 | $2,863 |
| Pregabalin | 115 | $1,983 |
| Gabapentin | 137 | $1,796 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $1,698 |
| Risedronate Sodium | 12 | $1,612 |
| Tramadol Hcl | 139 | $1,350 |
Paid to pharmacies, not to this prescriber.
Other general practice in Honolulu
- Philip SuhHonolulu$299K
- Kent HironakaHonolulu$94K
- Jason AkoHonolulu$81K
- Wynn OkudaHonolulu$60K
- Russell TacataHonolulu$22K
- Eugene AzumaHonolulu$14K
- Blake KitamuraHonolulu$11K
- Lance TeramotoHonolulu$8K
- Kyrell WrightHonolulu$7K
- Ann HashitateHonolulu$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.